Briacell Therapeutics earnings were -$11.8M for the trailing 12 months ending Jan 31, 2025, with N/A growth year over year. The latest BCTX earnings report on Jan 31, 2025 announced Q1 2025 earnings of -$6.3M, up 9.2% from last quarter. For the last reported fiscal year 2024 ending Jul 31, 2024, BCTX reported annual earnings of -$4.9M, with -75.7% growth.
Briacell Therapeutics Earnings Reports & History FAQ
What were Briacell Therapeutics's earnings last quarter?
On BCTX's earnings call on Invalid Date, Briacell Therapeutics (NASDAQ: BCTX) reported Q4 2024 earnings per share (EPS) of -$2.33, up 78.1% year over year. Total BCTX earnings for the quarter were -$6.34 million. In the same quarter last year, Briacell Therapeutics's earnings per share (EPS) was -$10.64.
Is Briacell Therapeutics profitable or losing money?
As of the last Briacell Therapeutics earnings report, Briacell Therapeutics is currently losing money. Briacell Therapeutics's net profit (also called net income) for the twelve months ending Jan 31, 2025 was -$11.78 million, a 6.86% decrease year over year.
What was BCTX's earnings growth in the past year?
As of Briacell Therapeutics's earnings date in Invalid Date, Briacell Therapeutics's earnings has grown year over year. BCTX earnings in the past year totalled -$11.78 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.